Study immune changes in adults with septic shock
Treatments studied
Part of Infections clinical trials.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You are currently admitted to an ICU
- Septic shock was diagnosed within 48 hours of ICU admission
- You started medicine to keep blood pressure up (vasopressors) within the first 48 hours
- You had a high lactate level (greater than 2 mmol/L) around the time those blood-pressure medicines started
- A blood sample is available on day 3 or 4 (on lab working days), and you or your family agree to join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how doctors treat septic shock in the ICU to learn what works best. If you have septic shock, joining this study helps researchers understand which treatments are most effective, and you'll get the same care you would anyway.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
This study looks at how the immune system changes during sepsis, a life-threatening infection that can cause organ failure. By studying blood samples over time, researchers hope to find better ways to treat or prevent complications.
This trial tests a new approach to treating septic shock, a life-threatening condition where infection causes dangerously low blood pressure. It aims to see if a different way of managing fluids and medications can improve recovery compared to standard care.
This study looks at the bacteria in the gut of patients with sepsis in the ICU. It aims to understand how these bacteria change during critical illness, which could lead to better treatments.
This study looks at how a hormone system that controls blood pressure acts in people with septic shock (a severe infection causing low blood pressure). It compares patients with septic shock, sepsis without shock, cardiogenic shock, and healthy people to find differences that might lead to better treatments.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.